Harvard prof rides 17,000% return in a single stock to become a billionaire - MarketWatch
That's how it's done mate.
Moderna MRNA, +4.23% went public in late 2018, bursting on the Wall Street scene as the biggest biotech IPO in history. Timothy Springer, a Harvard medical professor, saw his stake in the company fatten his bottom line by a whopping $320 million by the end of the trading day.
After that, he REALLY got rich.
Less than two years later, and the 72-year-old has ridden a 17,000% return in his Moderna shares — which he paid about $5 million for in the company’s early stages — into the billionaire club, according to the latest figures from the Bloomberg Billionaires Index.
After that, he REALLY got rich.
Less than two years later, and the 72-year-old has ridden a 17,000% return in his Moderna shares — which he paid about $5 million for in the company’s early stages — into the billionaire club, according to the latest figures from the Bloomberg Billionaires Index.
Comment